XML 34 R26.htm IDEA: XBRL DOCUMENT v3.20.1
SHARE-BASED AWARDS AND STOCK OPTIONS (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Allocation of Share-Based Compensation Costs by Plan

The following table summarizes share-based compensation expense and the related income tax benefit recognized for our share-based awards and stock options:
 
Three Months Ended
 
March 31, 2020
 
March 31, 2019
 
 
 
 
 
(in thousands)
 
 
 
 
Share-based compensation expense
$
27,822

 
$
11,418

Income tax benefit
$
6,473

 
$
2,509


Schedule of Changes in Non-Vested Restricted Stock Awards Activity
The following table summarizes the changes in unvested restricted stock and performance awards for the three months ended March 31, 2020:
 
Shares
 
Weighted-Average
Grant-Date
Fair Value
 
 
 
 
 
(in thousands)
 
 
 
 
 
 
Unvested at December 31, 2019
1,844

 

$149.96

Granted
546

 
193.36

Vested
(553
)
 
116.66

Forfeited
(18
)
 
152.88

Unvested at March 31, 2020
1,819

 

$173.12


Schedule of Stock Option Activity
The following table summarizes stock option activity for the three months ended March 31, 2020: 
 
Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
 
Aggregate Intrinsic Value
 
 
 
 
 
 
 
 
 
(in thousands)
 
 
 
(years)
 
(in millions)
 
 
 
 
 
 
 
 
Outstanding at December 31, 2019
1,755

 

$74.06

 
6.5
 
$190.3
Granted
125

 
200.42

 
 
 
 
Forfeited
(2
)
 
113.48

 
 
 
 
Exercised
(383
)
 
64.38

 
 
 
 
Outstanding at March 31, 2020
1,495

 

$87.05

 
6.8
 
$85.5
 
 
 
 
 
 
 
 
Options vested and exercisable at March 31, 2020
1,097

 

$66.97

 
5.9
 
$84.8

Schedule of Stock Option Valuation Assumptions Fair value was estimated on the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:
 
Three Months Ended
 
March 31, 2020
 
March 31, 2019
 
 
 
 
Risk-free interest rate
1.24%
 
2.49%
Expected volatility
30%
 
30%
Dividend yield
0.39%
 
0.04%
Expected term (years)
5
 
5